↓ Skip to main content

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

Overview of attention for article published in BMC Musculoskeletal Disorders, December 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]
Published in
BMC Musculoskeletal Disorders, December 2005
DOI 10.1186/1471-2474-6-58
Pubmed ID
Authors

Sean P Curtis, Barry Bockow, Chester Fisher, Joseph Olaleye, Amy Compton, Amy T Ko, Alise S Reicin

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Brazil 1 2%
Unknown 48 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 22%
Researcher 4 8%
Student > Ph. D. Student 4 8%
Student > Doctoral Student 3 6%
Student > Postgraduate 3 6%
Other 10 20%
Unknown 15 30%
Readers by discipline Count As %
Medicine and Dentistry 16 32%
Agricultural and Biological Sciences 4 8%
Nursing and Health Professions 2 4%
Business, Management and Accounting 2 4%
Arts and Humanities 2 4%
Other 10 20%
Unknown 14 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2023.
All research outputs
#7,787,714
of 24,960,237 outputs
Outputs from BMC Musculoskeletal Disorders
#1,511
of 4,342 outputs
Outputs of similar age
#39,393
of 158,527 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#2
of 6 outputs
Altmetric has tracked 24,960,237 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 4,342 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,527 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.